Bubble Continuous Positive Airway Pressure (bCPAP) has become a crucial intervention in neonatal care, particularly in resource‐limited settings where access to advanced respiratory support is scarce. While bCPAP offers a… Click to show full abstract
Bubble Continuous Positive Airway Pressure (bCPAP) has become a crucial intervention in neonatal care, particularly in resource‐limited settings where access to advanced respiratory support is scarce. While bCPAP offers a cost‐effective solution for neonatal respiratory distress, conducting clinical trials in these settings presents significant ethical challenges. Issues of justice, beneficence, and autonomy arise due to disparities in healthcare infrastructure, complexities surrounding informed consent, and the potential exploitation of vulnerable populations.
               
Click one of the above tabs to view related content.